Detalhe da pesquisa
1.
Esketamine inhaled as dry powder: Pharmacokinetic, pharmacodynamic and safety assessment in a preclinical study.
Pulm Pharmacol Ther
; 73-74: 102127, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35429651
2.
Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil.
J Enzyme Inhib Med Chem
; 35(1): 1743-1750, 2020 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32938236
3.
Pyrroloquinoline scaffold-based 5-HT6R ligands: Synthesis, quantum chemical and molecular dynamic studies, and influence of nitrogen atom position in the scaffold on affinity.
Bioorg Med Chem
; 26(12): 3588-3595, 2018 07 23.
Artigo
Inglês
| MEDLINE | ID: mdl-29853337
4.
Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists.
Pharmaceuticals (Basel)
; 14(8)2021 Jul 21.
Artigo
Inglês
| MEDLINE | ID: mdl-34451801
5.
Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties.
Eur J Med Chem
; 185: 111857, 2020 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31734022
6.
2-Aminoimidazole-based antagonists of the 5-HT6 receptor - A new concept in aminergic GPCR ligand design.
Eur J Med Chem
; 179: 1-15, 2019 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31229883
7.
Synthesis and characterization of novel classes of PDE10A inhibitors - 1H-1,3-benzodiazoles and imidazo[1,2-a]pyrimidines.
Eur J Med Chem
; 155: 96-116, 2018 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29870883